Transplantation for cholangiocarcinoma
Debra L. Sudan – 18 October 2006
Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis
Laura E. Moreno Luna, Gregory J. Gores – 18 October 2006
Budd‐Chiari syndrome: Case report
Michael F. Sorrell – 18 October 2006
Abnormal liver function tests in the patient transplanted 3 years ago for alcoholic liver disease
Nathan M. Bass, Bernard C. Portmann, Michael R. Lucey – 18 October 2006
Histologic findings in recurrent HBV
Swan N. Thung – 18 October 2006 – Key Concepts: 1The histopathologic presentation of hepatitis B (HB) infection in liver allografts is generally similar to that seen in the nonallografts.2An atypical pattern of recurrent HB, i.e., fibrosing cholestatic hepatitis (FCH) occurs in a small number of patients.
Abnormal liver function tests in a liver transplant recipient with hepatitis B virus: Report of a case
Timothy McCashland – 18 October 2006
Detection of HCV antigens in liver graft: Relevance to the management of recurrent post‐liver transplant hepatitis C
Alberto Grassi, Chiara Quarneti, Matteo Ravaioli, Francesco Bianchini, Micaela Susca, Antonia D'Errico, Fabio Piscaglia, Maria Rosa Tamè, Pietro Andreone, GianLuca Grazi, Silvia Galli, Daniela Zauli, Antonio D. Pinna, Francesco B. Bianchi, Giorgio Ballardini – 9 October 2006 – The aim of this study was to evaluate how the immunohistochemical detection of liver hepatitis C virus (HCV) antigens (HCV‐Ag) could support the histologic diagnosis and influence the clinical management of post‐liver transplantation (LT) liver disease.
Impact of adult‐to‐adult living donor liver transplantation on access to transplantation and patients' survival: An 8‐year single‐center experience
Jérôme Dumortier, Mustapha Adham, Charles Ber, Catherine Boucaud, Yves Bouffard, Bertrand Delafosse, Pierre Sagnard, Olivier Boillot – 9 October 2006 – While the number of candidates for liver transplantation has increased in the recent years, the pool of cadaveric donor organs has remained constant and the waiting time progressively increases. These facts led us to start a program of adult‐to‐adult living‐donor liver transplantation in 1998. The aim of this study was to compare the outcome of all patients put on the waiting list since 1998.
Low viscosity histidine‐tryptophan‐ketoglutarate graft flush improves subsequent extended cold storage in University of Wisconsin solution in an extracorporeal rat liver perfusion and rat liver transplantation model
Gero Puhl, Peter Olschewski, Wenzel Schöning, Gerhard Hunold, Hans‐Georg Liesaus, Robert Winkler, Ulf P. Neumann, Thomas E.O. Schubert, Volker Schmitz, Peter Neuhaus – 9 October 2006 – Adequate flushing for liver donation requires large fluid volumes delivered at a high flow. This can be achieved more effectively with crystalloid solutions than with colloid‐based solutions. This study examined the combination of initial histidine‐tryptophan‐ketoglutarate solution (HTK) graft flush and subsequent storage in University of Wisconsin solution (UW) to that of the single use of each solution.